Germ cell tumors of the ovary

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 1, 1997, Pages 44-47

  Talerman, Alexander ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; LACTATE DEHYDROGENASE; STREPTOZOCIN; VINBLASTINE;

CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOID; CLINICAL TRIAL; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; GONADAL DYSGENESIS; GONADOBLASTOMA; HUMAN; HYSTERECTOMY; KARYOTYPE; OVARY TUMOR; PRIORITY JOURNAL; REVIEW; YOLK SAC TUMOR;

EID: 0030944182     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199702000-00010     Document Type: Review

References (18)

1. Talerman A: Germ cell tumours of the ovary. In Blaustein's Pathology of the Female Genital Tract, edn 4. Edited by Kurman RJ. New York: Springer-Verlag; 1994:849-914.
2. Nogales FF: Germ cell tumours of the ovary. In Haines and Taylor Obstetrical and Gynaceological Pathology, edn 4. Edited by Fox H. New York: Churchill Livingstone; 1994:847-896.
3. Talerman A: Mixed germ cell sex cord-stromal tumours of the ovary. In Haines and Taylor Obstetrical and Gynecological Pathology, edn 4. Edited by Fox H. New York: Churchill Livingstone; 1994:897-919.
4. Peccatori F, Bonazzi C. Chiari F, Landoni F, Colombo N, Mangioni C: Surgical management of malignant ovarian germ-cell tumours: 10 years' experience with 129 patients. Obstet Gynecol 1995, 86:367-372. An informative, up-to-date, comprehensive study describing surgical and chemotherapeutic management of patients with malignant germ cell tumors of the ovary. It emphasizes the value of cisplatin-based chemotherapy, the very good results with appropriate treatment, and advocates fertility-sparing surgery in this group of patients.
5. Piura B, Dgani R, Zalel Y, Nemet D, Yanai-Inbar I, Cohen Y, Glazerman M: Malignant germ cell tumours of the ovary: a study of 20 cases. J Surg Oncol 1995, 59:155-167.
6. Bonazzi C, Peccatori F, Colombo N, Lucchini V, Cantu MG, Mangioni C: Pure ovarian immature teratoma, a unique and curable disease: 10 years experience of 32 prospectively treated patients. Obstet Gynecol 1994, 84:598-604.
7. Ayhan A, Tuncer ZS, Yanik F, Bukulmez O, Yanik A, Kucukali T: Malignant germ cell tumours of the ovary: Hacettepe Hospital experience. Acta Obstet Gynecol Scand 1995, 74:384-390.
8. Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Droz JP: Long term results of two VAB-like regimens (Vinblastine + Actinomycin D + Bleomycin + Cyclophosphamide + Cisplatin) in malignant germ cell tumours of the ovary. Eur J Cancer 1994, 30:1239-1244.
9. Williams SD, Blessing JA, Hatch KD, Homesley HD: Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. J Clin Oncol 1991, 9:1950-1955.
10. Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Gerbaulet A, Droz JP: Cisplatin based chemotherapy in dysgerminoma of the ovary: thirteen-year experience of the Institute Gustave Roussy. Gynecol Oncol 1995, 58:344-348.
11. Zhang R, Hong W, Li S: Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases [In Chinese]. Chung Hua Fu Chan Ko Tsa Chih (Chinese J Obstet Gynecol) 1995, 30:550-552.
12. Kojs Z, Urbanski K, Jakubowicz J, Rehfuss M: Pure dysgerminoma of the ovary: analysis of 25 cases [in Polish]. Ginekol Pol (Polish J Gynecol) 1995, 66:220-222.
13. Levato F, Mastinello R, Campobasso C, Porto S: LDH and LDH isoenzymes in ovarian dysgerminoma. Eur J Gynecol Oncol 1995, 16:212-215.
14. Talerman A: Ovarian pathology. Curr Opin Obstet Gynecol 1992, 4:608-615.
15. Davis KP, Hartmann LK, Keeney GL, Shapiro H: Primary ovarian carcinoid tumours. Gynecol Oncol 1996, 61:259-265. A series of primary carcinoid tumors of the ovary that includes a large proportion of advanced patients, this paper together with a review of the literature provides insights into the behavior and management of these neoplasms.
16. Obata NH, Nakashima N, Kawai M, Kikkawa F, Mamba S, Tomoda Y: Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46,XX karyotype. Gynecol Oncol 1995, 58:124-128. A well documented case report showing that gonadoblastoma may originate in normal ovaries of patients with 46,XX karyotype.
17. Letterie GS, Page DC: Dysgerminoma and gonadal dysgenesis in 46,XX female with no evidence of Y chromosomal DNA. Gynecol Oncol 1995, 57:423-425.
18. Kemp B, Hauptmann S, Schroder W, Amo-Takyi B, Leeners B, Rath W: Dysgerminoma of the ovary in a patient with triple-X syndrome. Int J Obstet Gynecol 1995, 50:51-53.